Loading clinical trials...
Loading clinical trials...
The open-label prospective non-randomised controlled aims to assess the efficacy of the combination of immunosupression (IST) and tonsillectomy (TE) in Caucasian patients at high risk of the IgA-nephr...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
St. Petersburg State Pavlov Medical University
NCT07322263 · Bladder Cancer, Non-Muscle Invasive Bladder Cancer (NMIBC), and more
NCT07523555 · Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia, Relapsed/Refractory B-cell Non-Hodgkin Lymphoma or CLL/SLL, and more
NCT07333547 · High-risk Cardiac Patients
NCT06057948 · Neuroblastoma, High-risk Neuroblastoma, and more
NCT07027124 · Prostate Cancer, High-risk Prostate Cancer
Research Institute of Nephrology (Pavlov Medical University)
Saint Petersburg
St. Petersburg State Pavlov Medical University
Saint Petersburg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions